Article thumbnail

Binding of sulphonated indigo derivatives to RepA-WH1 inhibits DNA-induced protein amyloidogenesis

By Fátima Gasset-Rosa, María Jesús Maté, Cristina Dávila-Fajardo, Jerónimo Bravo and Rafael Giraldo

Abstract

The quest for inducers and inhibitors of protein amyloidogenesis is of utmost interest, since they are key tools to understand the molecular bases of proteinopathies such as Alzheimer, Parkinson, Huntington and Creutzfeldt–Jakob diseases. It is also expected that such molecules could lead to valid therapeutic agents. In common with the mammalian prion protein (PrP), the N-terminal Winged-Helix (WH1) domain of the pPS10 plasmid replication protein (RepA) assembles in vitro into a variety of amyloid nanostructures upon binding to different specific dsDNA sequences. Here we show that di- (S2) and tetra-sulphonated (S4) derivatives of indigo stain dock at the DNA recognition interface in the RepA-WH1 dimer. They compete binding of RepA to its natural target dsDNA repeats, found at the repA operator and at the origin of replication of the plasmid. Calorimetry points to the existence of a major site, with micromolar affinity, for S4-indigo in RepA-WH1 dimers. As revealed by electron microscopy, in the presence of inducer dsDNA, both S2/S4 stains inhibit the assembly of RepA-WH1 into fibres. These results validate the concept that DNA can promote protein assembly into amyloids and reveal that the binding sites of effector molecules can be targeted to inhibit amyloidogenesis

Topics: Molecular Biology
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2367726
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). 20 years of the pPS10 replicon: insights on the molecular mechanism for the activation of DNA replication in iteron-containing bacterial plasmids.
  2. (2002). A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
  3. (2003). A conformational switch between transcriptional repression and replication initiation in the RepA dimerization domain.
  4. (2007). Alzheimer’s disease: progress in the development of anti-amyloid disease-modifying therapies.
  5. (1998). Automated docking using Nucleic Acids Research,
  6. (2007). Defined DNA sequences promote the assembly of a bacterial protein into distinct amyloid nanostructures.
  7. (2001). DNA converts cellular prion protein into the b-sheet conformation and inhibits prion peptide aggregation.
  8. (2002). DNA-induced partial unfolding of prion protein leads to its polymerization to amyloid.
  9. (2006). Early events in the binding of the pPS10 replication protein RepA to single iteron and operator DNA sequences.
  10. (2007). Formation of native prions from minimal components in vitro.
  11. (1992). Genetic and functional analysis of the basic replicon of pPS10, a plasmid specific of Pseudomonas isolated from Pseudomonas syringae pv.
  12. (2006). Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives.
  13. (1999). Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition.
  14. (2004). Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
  15. (1998). Prions.
  16. (2005). Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.
  17. (1998). Protein domains and conformational changes in the activation of RepA, a DNA replication initiator.
  18. (2006). Protein misfolding, functional amyloid, and human disease.
  19. (1989). Rapid measurements of binding constants and heats of binding using a new titration calorimeter.
  20. (2003). RNA molecules stimulate prion protein conversion.
  21. (2007). Selective incorporation of polyanionic molecules into hamster prions.
  22. (2007). Small molecule inhibitors of aggregation indicate that amyloid b oligomerization and fibrillization pathways are independent and distinct.
  23. (2007). Structural basis for regulation of bifunctional roles in replication initiator protein.
  24. (2003). Structural changes in RepA, a plasmid replication initiator, upon binding to origin DNA.
  25. (2006). Structural insights into the interaction between prion protein and nucleic acid.
  26. (2007). Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites.
  27. (1995). Transcription of repA, the gene of the initiation protein of the Pseudomonas plasmid pPS10, is autorregulated by interactions of the RepA protein at a symmetrical operator.